National generic immunotherapy consent form

The consent form project team is pleased to announce that the national generic immunotherapy consent form has been reviewed and is now available on the CRUK website at: www.cruk.org/sact_consent.

The national generic immunotherapy consent form was first published and available for use on the CRUK website in December 2016.  During the process of revalidation, in collaboration with the SACT consent form national steering group, and taking into consideration users feedback over the years, we have made some changes to the reviewed version.  Some of the changes include:

  • Tick box for gender removed.
  • A small section on compliance with clinical management guideline/protocol added to page 3.
  • Footer note included on all 5 pages where the specific immunotherapy drug name can be documented.
  • A link to the SACT treatment record on page 3
  • A statement and link on page 5 referring to the NHS Scotland legal framework

We are very close to completing the reviews for the breast consent forms. We will inform you of their availability on the CRUK webpage in due course.

Please share this update within your clinical teams or forward to the relevant  lead cancer clinician for your organisation.

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article